Related Experiment Video
Updated: Mar 8, 2026
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
9.3K
Dendrimers as nanocarriers for nucleoside analogues
Michał Gorzkiewicz1, Barbara Klajnert-Maculewicz2
1Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland.
Summary
Dendrimers show promise as nanocarriers for nucleoside analogues, improving drug delivery for cancer and viral therapies. These drug delivery systems enhance solubility, loading capacity, and target specificity for nucleoside analogue treatments.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Pharmacology
Background:
- Dendrimers are hyperbranched macromolecules with unique properties like defined structure and multivalency.
- They are recognized as promising nanocarriers for drug delivery, enhancing solubility and loading capacity.
- Dendrimers offer potential in cancer therapy by delivering drugs directly to cancer cells and overcoming resistance.
Purpose of the Study:
- To review the application of dendrimers as delivery devices for nucleoside analogues (NAs).
- To explore how dendrimers can improve the efficacy and specificity of NA-based therapies.
- To summarize data on dendrimers for delivering NAs and their active triphosphate forms.
Main Methods:
- Literature review of studies on dendrimers and nucleoside analogues.
- Analysis of dendrimer properties relevant to drug delivery.
- Evaluation of dendrimer-based delivery for antiviral and anticancer nucleoside analogues.
Main Results:
- Dendrimers can improve solubility, loading capacity, and biodistribution of nucleoside analogues.
- They show potential in overcoming drug resistance in cancer therapies, particularly for leukemia.
- Dendrimers can facilitate targeted delivery of nucleoside analogues and their active forms.
Conclusions:
- Dendrimers represent a viable drug delivery system for nucleoside analogues.
- Their unique properties enhance the therapeutic potential of nucleoside analogues in treating viral infections and cancers.
- Further research into dendrimer-NA conjugates could lead to more effective treatments.
